Hot Melt Extrusion - Improving Solubility and Bioavailability of Poorly Soluble Molecules

[Article Title]

Poor aqueous solubility is a major barrier to oral drug delivery, often leading to low bioavailability and compromised therapeutic outcomes. This article explores how hot-melt extrusion (HME) is emerging as a powerful solution, enabling pharmaceutical developers to enhance solubility, improve bioavailability, and create robust solid dispersions.

With a focus on formulation strategies and key process parameters, the piece outlines how HME compares to traditional techniques, and why it is gaining traction across both research and commercial manufacturing. You'll also learn about the versatility of HME in handling a wide range of APIs and how it aligns with continuous manufacturing trends.

Download the full article to dive deeper into the science, advantages, and evolving role of hot-melt extrusion in modern drug development.

Download the Document

    * denotes a required field

    Please fill out the information below. If you are already registered, and this information will be filled out for you.

  • Please enter your first and last name.

  • Please enter the name of the company or institution you work at.

  • Please enter your mailing address.

  • Please enter the e-mail address you would like to be contacted at.

  • Please enter the phone number you would like to be contacted at.

    • By submitting this form, you consent to American Pharmaceutical Review storing your email address and contact information and transmitting your contact information to the content sponsor. You may request to be removed at any time.